Transforming Life Sciences with AI
BiomixX is building an AI-powered bioinformatics agent that solves a critical bottleneck in life sciences research: biological interpretation.
Every pharmaceutical company, biotech, and research institution generating omics data faces the same problem—scientists spend most of their time interpreting data instead of making discoveries. Current solutions are fragmented, slow, and require specialized expertise.
BiomixX changes this. Our platform automatically integrates statistical outputs, disease-specific literature, pathways, protein networks, and structural insights—delivering clear biological stories in minutes instead of weeks.
We're starting with proteomics, where the need is most acute, then expanding to metabolomics, transcriptomics, genomics, and lipidomics. Our ultimate vision is an integrated multi-omics platform that reflects how biology actually works—interconnected and holistic.
Proprietary AI that doesn't just analyze data, but tells biological stories with automated narrative generation and context-aware insights.
The first true AI agent for comprehensive biological interpretation—positioned between basic tools and expensive bioinformatics teams.
SaaS platform with expanding capabilities across all omics technologies, serving academia, pharma, biotech, and clinical research.
Once integrated into research workflows, BiomixX becomes essential infrastructure for discovery.
Unlike traditional tools that require manual interpretation, BiomixX provides automated biological storytelling
Single solution replacing multiple disconnected tools and databases
Minutes instead of weeks for comprehensive biological interpretation
Democratizes advanced bioinformatics for all researchers
We're currently raising capital to accelerate product development and market expansion.
For detailed information including our pitch deck, financials, and growth strategy, please contact us:
From weeks to minutes for biological interpretation
Comprehensive analysis vs. traditional fragmented approaches
Recurring revenue model with expanding capabilities
Platform designed for all omics technologies